Two antiviral drugs are available in Australia, but one is prescribed more routinely. Here’s what you need to know as we navigate the eighth COVID wave.
Rigor acadêmico, estilo jornalístico
Todos os artigos de Lagevrio
Exibindo todos artigos
How are people with long COVID faring two years after their initial infection? Many have recovered. Some still struggle with symptoms – this is more likely for those who were initially hospitalised.
People in disadvantaged communities are less likely to access COVID antivirals. That needs to change.
Just as access to vaccines was vastly more difficult for low-income countries, the same is now true for the virus’ treatments: at potentially great cost to the world.
Principais colaboradores
-
Associate Professor in Public Health, La Trobe University
-
Senior Technical Advisor - HIV, The Nossal Institute for Global Health, PhD candidate La Trobe University, The University of Melbourne
-
Post doctoral researcher and medical epidemiologist, The Peter Doherty Institute for Infection and Immunity
-
Director and CEO, Burnet Institute
-
Associate Professor and Chief Health Officer - COVID and Health Emergencies, Burnet Institute
-
Associate Lecturer, Sydney Pharmacy School, University of Sydney
-
Professor and Director Academic Excellence, Macquarie University
